SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1nd7'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4G_B_ZMRB466_2
(NEURAMINIDASE)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		3 / 3 ASP A 712
ARG A 711
ILE A 693
 None
 0.68A 1a4gB-1nd7A:
undetectable		 1a4gB-1nd7A:
21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C4D_B_DVAB8_0
(GRAMICIDIN A)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		3 / 3 TRP A 812
VAL A 817
TRP A 832
 None
 1.22A 1c4dA-1nd7A:
undetectable
1c4dB-1nd7A:
undetectable		 1c4dA-1nd7A:
4.49
1c4dB-1nd7A:
4.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FIQ_C_SALC1335_1
(XANTHINE OXIDASE)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 8 LEU A 896
VAL A 850
LEU A 846
ALA A 912
 None
 0.87A 1fiqC-1nd7A:
undetectable		 1fiqC-1nd7A:
19.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P2Y_A_NCTA440_1
(CYTOCHROME P450-CAM)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 7 PHE A 831
LEU A 847
VAL A 850
ILE A 875
 None
 0.69A 1p2yA-1nd7A:
0.0		 1p2yA-1nd7A:
21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QKU_A_ESTA600_1
(ESTRADIOL RECEPTOR)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		5 / 10 GLU A 798
LEU A 680
ARG A 855
ILE A 699
LEU A 691
 None
 1.41A 1qkuA-1nd7A:
undetectable		 1qkuA-1nd7A:
21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QKU_B_ESTB600_1
(ESTRADIOL RECEPTOR)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		5 / 10 GLU A 798
LEU A 680
ARG A 855
ILE A 699
LEU A 691
 None
 1.42A 1qkuB-1nd7A:
undetectable		 1qkuB-1nd7A:
21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QKU_C_ESTC600_1
(ESTRADIOL RECEPTOR)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		5 / 10 GLU A 798
LEU A 680
ARG A 855
ILE A 699
LEU A 691
 None
 1.42A 1qkuC-1nd7A:
undetectable		 1qkuC-1nd7A:
21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SG9_A_SAMA301_0
(HEMK PROTEIN)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		5 / 12 PHE A 659
ILE A 643
GLY A 661
THR A 773
GLU A 771
 None
 1.17A 1sg9A-1nd7A:
undetectable		 1sg9A-1nd7A:
22.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T87_B_CAMB2422_0
(CYTOCHROME P450-CAM)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 7 PHE A 831
LEU A 847
VAL A 850
ILE A 875
 None
 0.80A 1t87B-1nd7A:
undetectable		 1t87B-1nd7A:
21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YAJ_K_BEZK4387_0
(CES1 PROTEIN)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		3 / 3 TRP A 883
LEU A 884
LYS A 908
 None
 1.45A 1yajK-1nd7A:
undetectable		 1yajK-1nd7A:
23.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JFA_B_RALB600_1
(ESTROGEN RECEPTOR)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		5 / 12 ALA A 775
ASP A 778
LEU A 777
LEU A 630
GLY A 768
 None
 1.11A 2jfaB-1nd7A:
undetectable		 2jfaB-1nd7A:
21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QBL_A_CAMA517_0
(CYTOCHROME P450-CAM)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 7 PHE A 831
LEU A 847
VAL A 850
THR A 851
 None
 0.97A 2qblA-1nd7A:
0.0		 2qblA-1nd7A:
22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V2G_A_BEZA1222_0
(PEROXIREDOXIN 6)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 7 THR A 575
VAL A 571
SER A 572
ARG A 601
 None
 0.93A 2v2gA-1nd7A:
undetectable
2v2gB-1nd7A:
undetectable		 2v2gA-1nd7A:
20.26
2v2gB-1nd7A:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V2G_B_BEZB1220_0
(PEROXIREDOXIN 6)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 7 THR A 575
VAL A 571
SER A 572
ARG A 601
 None
 0.93A 2v2gA-1nd7A:
undetectable
2v2gB-1nd7A:
undetectable		 2v2gA-1nd7A:
20.26
2v2gB-1nd7A:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V2G_C_BEZC1222_0
(PEROXIREDOXIN 6)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 7 THR A 575
VAL A 571
SER A 572
ARG A 601
 None
 0.94A 2v2gC-1nd7A:
undetectable
2v2gD-1nd7A:
undetectable		 2v2gC-1nd7A:
20.26
2v2gD-1nd7A:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V2G_D_BEZD1221_0
(PEROXIREDOXIN 6)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 7 THR A 575
VAL A 571
SER A 572
ARG A 601
 None
 0.92A 2v2gC-1nd7A:
undetectable
2v2gD-1nd7A:
undetectable		 2v2gC-1nd7A:
20.26
2v2gD-1nd7A:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V32_A_BEZA1222_0
(PEROXIREDOXIN 6)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 8 THR A 575
VAL A 571
SER A 572
ARG A 601
 None
 0.91A 2v32A-1nd7A:
undetectable
2v32B-1nd7A:
undetectable		 2v32A-1nd7A:
20.26
2v32B-1nd7A:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V32_B_BEZB1220_0
(PEROXIREDOXIN 6)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 8 THR A 575
VAL A 571
SER A 572
ARG A 601
 None
 0.94A 2v32A-1nd7A:
undetectable
2v32B-1nd7A:
undetectable		 2v32A-1nd7A:
20.26
2v32B-1nd7A:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V32_C_BEZC1222_0
(PEROXIREDOXIN 6)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 8 THR A 575
VAL A 571
SER A 572
ARG A 601
 None
 0.91A 2v32C-1nd7A:
undetectable
2v32D-1nd7A:
undetectable		 2v32C-1nd7A:
20.26
2v32D-1nd7A:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V32_D_BEZD1221_0
(PEROXIREDOXIN 6)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 8 THR A 575
VAL A 571
SER A 572
ARG A 601
 None
 0.92A 2v32C-1nd7A:
undetectable
2v32D-1nd7A:
undetectable		 2v32C-1nd7A:
20.26
2v32D-1nd7A:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V41_C_BEZC1218_0
(PEROXIREDOXIN 6.)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 8 THR A 575
VAL A 571
SER A 572
ARG A 601
 None
 0.91A 2v41C-1nd7A:
undetectable
2v41D-1nd7A:
undetectable		 2v41C-1nd7A:
20.26
2v41D-1nd7A:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V41_D_BEZD1222_0
(PEROXIREDOXIN 6.)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 8 THR A 575
VAL A 571
SER A 572
ARG A 601
 None
 0.93A 2v41C-1nd7A:
undetectable
2v41D-1nd7A:
undetectable		 2v41C-1nd7A:
20.26
2v41D-1nd7A:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V41_E_BEZE1222_0
(PEROXIREDOXIN 6.)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 7 THR A 575
VAL A 571
SER A 572
ARG A 601
 None
 0.93A 2v41E-1nd7A:
undetectable
2v41F-1nd7A:
undetectable		 2v41E-1nd7A:
20.26
2v41F-1nd7A:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V41_F_BEZF1222_0
(PEROXIREDOXIN 6.)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 7 THR A 575
VAL A 571
SER A 572
ARG A 601
 None
 0.91A 2v41E-1nd7A:
undetectable
2v41F-1nd7A:
undetectable		 2v41E-1nd7A:
20.26
2v41F-1nd7A:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V41_H_BEZH1222_0
(PEROXIREDOXIN 6.)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 8 THR A 575
VAL A 571
SER A 572
ARG A 601
 None
 0.91A 2v41G-1nd7A:
undetectable
2v41H-1nd7A:
undetectable		 2v41G-1nd7A:
20.26
2v41H-1nd7A:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W3A_A_TOPA1190_1
(DIHYDROFOLATE
REDUCTASE)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		5 / 11 ILE A 674
ALA A 665
PHE A 659
PHE A 663
ILE A 569
 None
 1.20A 2w3aA-1nd7A:
undetectable		 2w3aA-1nd7A:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W3A_B_TOPB1189_1
(DIHYDROFOLATE
REDUCTASE)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		5 / 10 ILE A 674
ALA A 665
PHE A 659
PHE A 663
ILE A 569
 None
 1.19A 2w3aB-1nd7A:
undetectable		 2w3aB-1nd7A:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W9H_A_TOPA1160_1
(DIHYDROFOLATE
REDUCTASE)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		6 / 10 ALA A 912
LEU A 909
LEU A 846
VAL A 850
ILE A 875
THR A 916
 None
 1.43A 2w9hA-1nd7A:
undetectable		 2w9hA-1nd7A:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YVL_C_SAMC604_0
(HYPOTHETICAL PROTEIN)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		5 / 12 GLY A 661
ALA A 775
LEU A 777
ALA A 667
VAL A 784
 None
 1.24A 2yvlC-1nd7A:
undetectable		 2yvlC-1nd7A:
20.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HRD_E_NIOE5660_1
(NICOTINATE
DEHYDROGENASE LARGE
MOLYBDOPTERIN
SUBUNIT
NICOTINATE
DEHYDROGENASE MEDIUM
MOLYBDOPTERIN
SUBUNIT)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		3 / 3 GLU A 717
GLU A 716
TRP A 709
 None
 1.34A 3hrdA-1nd7A:
0.0
3hrdE-1nd7A:
0.0
3hrdF-1nd7A:
0.0		 3hrdA-1nd7A:
19.20
3hrdE-1nd7A:
19.20
3hrdF-1nd7A:
18.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQW_B_ACHB323_0
(ELIC PENTAMERIC
LIGAND GATED ION
CHANNEL FROM ERWINIA
CHRYSANTHEMI)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		5 / 9 ASN A 650
GLU A 578
TYR A 628
LEU A 630
PHE A 577
 None
 1.49A 3rqwB-1nd7A:
1.4
3rqwC-1nd7A:
1.3		 3rqwB-1nd7A:
21.30
3rqwC-1nd7A:
21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQW_C_ACHC323_0
(ELIC PENTAMERIC
LIGAND GATED ION
CHANNEL FROM ERWINIA
CHRYSANTHEMI)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 8 ASN A 650
GLU A 578
TYR A 628
PHE A 577
 None
 1.11A 3rqwC-1nd7A:
undetectable
3rqwD-1nd7A:
undetectable		 3rqwC-1nd7A:
21.30
3rqwD-1nd7A:
21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQW_I_ACHI323_0
(ELIC PENTAMERIC
LIGAND GATED ION
CHANNEL FROM ERWINIA
CHRYSANTHEMI)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		5 / 8 ASN A 650
GLU A 578
TYR A 628
LEU A 630
PHE A 577
 None
 1.49A 3rqwI-1nd7A:
undetectable
3rqwJ-1nd7A:
undetectable		 3rqwI-1nd7A:
21.30
3rqwJ-1nd7A:
21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQW_I_ACHI323_0
(ELIC PENTAMERIC
LIGAND GATED ION
CHANNEL FROM ERWINIA
CHRYSANTHEMI)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 8 PHE A 834
ILE A 828
LEU A 846
PHE A 873
 None
 1.04A 3rqwI-1nd7A:
undetectable
3rqwJ-1nd7A:
undetectable		 3rqwI-1nd7A:
21.30
3rqwJ-1nd7A:
21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQW_J_ACHJ323_0
(ELIC PENTAMERIC
LIGAND GATED ION
CHANNEL FROM ERWINIA
CHRYSANTHEMI)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 8 GLU A 578
TYR A 628
PHE A 577
ASN A 650
 None
 1.12A 3rqwF-1nd7A:
undetectable
3rqwJ-1nd7A:
undetectable		 3rqwF-1nd7A:
21.30
3rqwJ-1nd7A:
21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L4C_B_CAMB502_0
(CAMPHOR
5-MONOOXYGENASE)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 8 PHE A 831
LEU A 847
VAL A 850
ILE A 875
 None
 0.93A 4l4cB-1nd7A:
0.0		 4l4cB-1nd7A:
22.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LJ0_A_ACTA505_0
(NAB2)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		3 / 3 LEU A 777
LYS A 774
THR A 773
 None
 0.59A 4lj0A-1nd7A:
undetectable		 4lj0A-1nd7A:
10.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DZK_U_BEZU801_0
(ATP-DEPENDENT CLP
PROTEASE PROTEOLYTIC
SUBUNIT 2
BEZ-LEU-LEU)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 6 PHE A 663
ALA A 665
HIS A 670
LEU A 592
 None
 1.26A 5dzkg-1nd7A:
undetectable
5dzku-1nd7A:
undetectable		 5dzkg-1nd7A:
21.45
5dzku-1nd7A:
2.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VEU_H_RITH602_1
(CYTOCHROME P450 3A5)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		5 / 12 SER A 620
LEU A 624
PHE A 678
ILE A 674
ALA A 667
 None
 1.03A 5veuH-1nd7A:
0.0		 5veuH-1nd7A:
21.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VEU_H_RITH602_1
(CYTOCHROME P450 3A5)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		5 / 12 SER A 620
LEU A 624
PHE A 678
ILE A 674
GLY A 779
 None
 1.03A 5veuH-1nd7A:
0.0		 5veuH-1nd7A:
21.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X1B_P_CHDP305_0
(CYTOCHROME C OXIDASE
SUBUNIT 3)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 5 LEU A 668
PHE A 669
PHE A 554
LEU A 789
 None
 1.04A 5x1bP-1nd7A:
undetectable		 5x1bP-1nd7A:
21.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X23_A_LSNA504_1
(CYTOCHROME P450 2C9)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 8 PHE A 657
ILE A 660
PHE A 631
PHE A 682
 None
 1.11A 5x23A-1nd7A:
0.0		 5x23A-1nd7A:
22.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X7P_B_ACRB1421_1
(GLYCOSIDE HYDROLASE
FAMILY 31
ALPHA-GLUCOSIDASE)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		4 / 6 GLU A 721
TYR A 723
GLY A 743
GLY A 742
 None
 0.91A 5x7pB-1nd7A:
undetectable		 5x7pB-1nd7A:
13.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6A93_A_8NUA3001_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 2A,SOLUBLE
CYTOCHROME B562)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		5 / 12 SER A 580
TRP A 615
THR A 676
LEU A 592
PHE A 776
 None
 1.34A 6a93A-1nd7A:
undetectable		 6a93A-1nd7A:
21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6A93_B_8NUB3001_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 2A,SOLUBLE
CYTOCHROME B562)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		5 / 12 SER A 580
TRP A 615
THR A 676
LEU A 592
PHE A 776
 None
 1.32A 6a93B-1nd7A:
undetectable		 6a93B-1nd7A:
21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G1P_B_ACTB403_0
(ADP-RIBOSYLHYDROLASE
LIKE 2)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		3 / 3 PHE A 891
ARG A 893
GLN A 871
 None
 1.03A 6g1pB-1nd7A:
0.0		 6g1pB-1nd7A:
23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GNG_A_QPSA601_1
(-)		 1nd7 WW DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens) 		5 / 12 GLY A 860
LEU A 858
THR A 851
GLY A 852
GLN A 805
 None
 0.98A 6gngA-1nd7A:
undetectable		 6gngA-1nd7A:
20.00